Categories: U.S.

Revance’s Botox rival gets FDA approval for painful neck muscle condition

close Video

Fox News Flash top headlines for August 15

Fox News Flash top headlines are here. Check out what’s clicking on Foxnews.com.

The U.S. health regulator has approved expanding the use of Revance Therapeutics’ Daxxify to treat a painful neck muscle condition, intensifying the anti-wrinkle injection’s rivalry with AbbVie’s Botox.

The approval by the Food and Drug Administration helps Revance enter the $2.5 billion U.S. market for therapeutic neuromodulator, a method that directly acts on nerves, the company said on Monday.

Cervical dystonia accounts for about $345 million of that market. The painful condition involves involuntary contraction of neck muscles and causes the head to twist to one side.

Revance will move into a preview phase with some doctors and key opinion leaders (KOLs) initially after the approval, company executives told Reuters before the decision.

“We’ll use that group as our faculty to then train that broader launch group which will be in 2024,” President Dustin Sjuts said.

KRISTIN CAVALLARI REVEALS WHY SHE WILL NEVER USE BOTOX

Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, on Aug. 29, 2020.  (REUTERS/Andrew Kelly/File Photo)

CLICK HERE TO GET THE FOX NEWS APP

Revance said it would share more information on the pricing when the product is launched commercially.

The company has been trying to attract clients to Daxxify from its more popular rival with its “Break Up with Botox” marketing campaign.

The newer anti-wrinkle injection recorded $22.6 million in sales in the second quarter. The California-based company is counting on Daxxify’s longer treatment duration to attract more doctors and patients from Botox.

Most cervical dystonia patients saw the treatment effect last about 20 weeks and 24 weeks when using different dosages of Daxxify, a late-stage study showed, compared with three months for Botox, as per FDA data.

This was similar for Daxxify when it had secured U.S. approval as an anti-wrinkle injection last year.

Share

Recent Posts

1 billion identity records exposed in ID verification data leak

Things like your name, home address, date of birth and even your Social Security number…

1 week ago

Android fixes 129 security flaws in major phone update

Most people never think about Android security updates until a headline like this appears. Suddenly,…

1 week ago

Burger King AI listens to workers

The next time you pull up to the drive-thru at Burger King, you may notice…

1 week ago

Fake Google Gemini AI pushes ‘Google Coin’ crypto scam

You may think you can spot a crypto scam from a mile away. But what…

1 week ago

Tesla builds a car with no steering wheel. Now what?

The first Tesla Cybercab has officially rolled off the floor at Tesla Gigafactory Texas. And…

1 week ago

Meta smart glasses privacy concerns grow

Smart glasses promise a future where technology blends into everyday life. You can ask a…

1 week ago